Head-to-head · computed 2026-08-11
Enhance MD vs Henry Meds
Enhance MD: Enhance MD bundles GLP-1 medication inside a broader metabolic program including NAD+ coaching, lab testing every six months, and ongoing provider care. The price reflects the full metabolic bundle, not the GLP-1 alone; this makes Enhance MD's figures the least comparable in the database. Henry Meds: Henry's all-inclusive semaglutide runs $297/month ($247 on 6-month and $197 on 12-month prepaid bundles) and tirzepatide $349/month; a separately marketed 'as low as $149' microdose floor is a different program.
Tirzepatide
| Enhance MD | Henry Meds | |
|---|---|---|
| All-in maintenance | $280/mo | $179/mo |
| Best plan rate | $280/mo | $179/mo |
| 12-month total | $3,360 | $2,148 |
| Status | Reported · 2026-07-14 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Henry Meds's $179 a month undercuts Enhance MD's $280 by $101 a month at the 10 mg/wk maintenance basis — $1,212 across a year. Henry Meds's figure is reported (captured 2026-07-14) and Enhance MD's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Enhance MD's tirzepatide ladder runs $280 a month billed monthly. Henry Meds's runs $179 a month billed monthly. On the twelve-month basis Henry Meds's $2,148 beats Enhance MD's $3,360 by $1,212 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Enhance MD | Henry Meds | |
|---|---|---|
| All-in maintenance | $212/mo | $179/mo |
| Best plan rate | $212/mo | $197/mo |
| 12-month total | $2,544 | $2,364 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Enhance MD's $212 a month undercuts Henry Meds's $297 by $85 a month at the 2.4 mg/wk maintenance basis — $1,020 across a year. Enhance MD's figure is reported (captured 2026-07-14) and Henry Meds's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Enhance MD's semaglutide ladder runs $212 a month billed monthly. Henry Meds's runs $297 a month billed monthly, $247 a month on a six-month plan, and $197 a month on a twelve-month plan. On the twelve-month basis Henry Meds's $2,364 beats Enhance MD's $2,544 by $180 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Henry Meds is dose-flat — the price survives titration — while Enhance MD's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On exit terms, Enhance MD's structure avoids prepaid lock-in while Henry Meds's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Enhance MD
- MembershipNone
- Dose policyBundled program; multiple tiers (Core $212, Elite tirz $322, Microdosing tirz $169)
- CommitmentMonthly, with a first-month discount on GLP-1 Core ($112 first month)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not named)
Henry Meds
- MembershipNone
- Dose policyFlat — $179/mo tirzepatide and $179/mo semaglutide at every dose, per reported sources
- CommitmentMonth-to-month; 6/12-month bundles prepaid
- CancellationCancel before renewal; bundle refunds limited
- PharmacyPartner pharmacies
What our desk is watching on each
Enhance MD: Figures reflect the bundled metabolic program price, not GLP-1 medication alone. Comparing Enhance MD's $212–$322 to medication-only programs overstates the GLP-1 cost while understating the breadth of service included. The $169 microdosing figure is the most medication-proximate but involves a different dosing protocol. Reported — RangeYourself 2026-07-14.
Henry Meds: Two independent 2026 captures (RangeYourself Jul 2026, RxPepsDirect May 2026) consistently show $179/mo flat for tirzepatide, replacing our Aug-5 $349 provider-stated figure. Henry's pharmacy partner is not publicly named. Semaglutide plan tiers ($179–$297) remain from our prior captures pending full reconciliation with the updated tirz figure.
Questions people ask
Is Enhance MD or Henry Meds cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Enhance MD vs Henry Meds miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Enhance MD and Henry Meds cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,360 at Enhance MD and $2,148 at Henry Meds — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Enhance MD · Henry Meds. Official sites: Enhance MD ↗ · Henry Meds ↗. Nothing here is medical advice.